Apr 09, 2019 (Heraldkeeper via COMTEX) -- New York, April 09, 2019: Global Testosterone Replacement Therapy Market is expected to exceed more than US$ 1.0 billion by 2024 at CAGR of 4% in the given forecast period.

The scope of the report includes a detailed study of global and regional markets of Testosterone Replacement Therapy Market. The reasons given for variations in the growth of the industry in certain regions.

Testosterone is responsible for the improvement of male sexual characteristics and this hormone formed by the testicles. It is also important to maintain various functions such as sexual function, bone growth, adequate levels of red blood cells, and a sense of well being and muscle bulk. Insufficient production of testosterone causes erectile dysfunction. Erectile dysfunction occurs due to decreased testosterone production to overcome this testosterone replacement therapy is used to improve the problem. Testosterone replacement therapy occurs in various forms containing its own set of advantages and hazards such as subdemal pellets, transdemal patches and injections. Testosterone replacement therapy also helps to recover symptoms of low testosterone. Low testosterone is caused due to age growth it generally lowers down after the mid 30's and further decreases accordingly to the age factor.

Browse Full Report: https://www.marketresearchengine.com/upcommingreport/testosterone-replacement-therapy-market

The major driving factors of testosterone replacement therapy market are as follows:

Rise in incidence of testosterone deficiency. Increase in geriatric populace with high risk of testosterone deficiency. Increasing awareness about testosterone substitute therapy.

The restraining factors of testosterone replacement therapy market are as follows:

High possibility of side effects associated to testosterone replacement therapy. Patent expiry of key drugs and entry of generics.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include AbbVie, Inc., Allergan plc, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Mylan N.V., Novartis AG, and Pfizer, Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Testosterone Replacement Therapy Market has been segmented as below:

The Testosterone Replacement Therapy Market is Segmented on the lines of Product Type Analysis, Ingredient Type Analysis and Regional Analysis. By Product Type Analysis this market is segmented on the basis of Oral, Implants, Gums/Buccal Adhesives, Injections, Patches and Creams/Gels.

By Ingredient Type Analysis this market is segmented on the basis of Testosterone, Testosterone Cypionate, Testosterone Enanthate, Testosterone Undecanoate and Methyl Testosterone. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific, MEA and Rest of the World.

This report provides:

1) An overview of the global market for testosterone replacement therapy and related technologies.

2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.

3) Identifications of new market opportunities and targeted promotional plans for testosterone replacement therapy.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

Request Sample Report from here: https://www.marketresearchengine.com/upcommingreport/testosterone-replacement-therapy-market

Table of Contents

1 INTRODUCTION

2 Executive Summary

3 Global Testosterone Replacement Therapy Market - Industry Analysis

4 North America Testosterone Replacement Therapy Market Analysis

5 Europe Testosterone Replacement Therapy Market Analysis

6 Asia Pacific Testosterone Replacement Therapy Market Analysis

7 Middle East and Africa (MEA) Testosterone Replacement Therapy Market Analysis

8 Latin America Testosterone Replacement Therapy Market Analysis

9 Global Testosterone Replacement Therapy Market, Country Snippets

9.1. Global Testosterone Replacement Therapy Market Revenue, by Country, (US$ Mn), 2014-2024 9.2. U.S. Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024 9.3. Japan Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024 9.4. Germany Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024 9.5. U.K. Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024 9.6. Canada Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024 9.7. China Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024 9.8. Brazil Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024 9.9. Mexico Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024 9.10. United Arab Emirates (UAE) Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024

10 Company Profiles

10.1. AbbVie, Inc.

10.2. Allergan plc

10.3. Bayer AG

10.4. Endo Pharmaceuticals, Inc.

10.5. Eli Lilly and Company

10.6. Kyowa Kirin International plc

10.7. Mylan N.V.

10.8. Novartis AG

10.9. Pfizer, Inc.

Other Related Market Research Reports:

Topical Drug Delivery Market Size, Industry Share, Approaches and Forecast By 2022

Tuberculosis Testing Market is Expected to Get US$ 2600 Million By 2022

Urinary Tract Infection Treatment Market is Expected to Grow US$ 10 Billion By 2024

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

Excerpt from:
Testosterone Replacement Therapy Market is Anticipated to ...